Spectrum Brands (SPB)
(Delayed Data from NYSE)
$91.29 USD
-1.61 (-1.73%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $91.27 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth F Momentum B VGM
Price, Consensus and EPS Surprise
SPB 91.29 -1.61(-1.73%)
Will SPB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SPB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SPB
Spectrum Brands' Pricing & Other Efforts Aid: Apt to Stay Invested?
SPB vs. K: Which Stock Should Value Investors Buy Now?
SPB: What are Zacks experts saying now?
Zacks Private Portfolio Services
SPB Stock Trades Near 52-Week High: Should You Buy or Play Safe?
Why Spectrum Brands (SPB) is a Top Growth Stock for the Long-Term
Why Spectrum Brands (SPB) is a Top Growth Stock for the Long-Term
Other News for SPB
Ex-Dividend Reminder: Spectrum Brands Holdings, Carter's and Monro
Superior Plus (SPB) Gets a Hold from National Bank
Superior Plus (SPB) Receives a Buy from Stifel Nicolaus
Spectrum Brands, Aperture Pet & Life partner to assist aquarists
Superior Plus Buy Rating Reaffirmed on Strong Fundamentals and Undervaluation